Key result
Clonal hematopoiesis of indeterminate potential (CHIP) was associated with a 42% increased risk of incident coronary heart disease compared with non-CHIP carriers.
Why the study?
How clonal hematopoiesis of indeterminate potential confers coronary heart disease risk in East Asian individuals, particularly those with small clones and differing genetic backgrounds, was completely unknown.
Does clonal hematopoiesis of indeterminate potential (CHIP), including small clones, increase the risk of incident coronary heart disease in a general Chinese population?
Cohort (n=6,181)
Yes
Does clonal hematopoiesis of indeterminate potential (CHIP), including small clones, increase the risk of incident coronary heart disease in a general Chinese population?
Hazard Ratio: 1.42 (95% CI 1.18–1.72)
p-value: p=2.82×10−4
Clonal hematopoiesis of indeterminate potential (CHIP), including small clones, significantly increases the risk of incident coronary heart disease, an effect that is amplified by high germline polygenic risk in inflammatory pathways.
No takes yet. Share an insight, caveat, or question.
CHIP mutations were associated with higher CHD risk amplified by PRS; leaves open whether screening or targeting CHIP alters outcomes.
Zhao et al. (2024) conducted a cohort in Coronary heart disease (n=6,181). Clonal hematopoiesis of indeterminate potential (CHIP) vs. Non-CHIP carriers was evaluated on First incident CHD (HR 1.42, 95% CI 1.18-1.72, p=2.82×10−4). Clonal hematopoiesis of indeterminate potential (CHIP) was associated with a 42% increased risk of incident coronary heart disease compared with non-CHIP carriers.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: